Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Actual dosing for any patient must be determined by a licensed medical provider based on individual health history, body composition goals, and concurrent treatments
BPC-157, TB-500, and GHK-Cu act directly at injury sites through specific molecular pathways
Small human studies are now starting: one trial in MS is testing oral sodium butyrates effect on MRI and immune markers [263]
The peptide is not FDA-approved for any indication, and carriers do not reimburse off-label peptide therapy regardless of the clinical justification
PubMed laboratory research record [PMID: 17303920] PubMed record related to this compound for laboratory literature review
US$ 23.30
US$ 29.94
US$ 25.44
US$ 20.78
US$ 25.80
